These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4589321)

  • 1. A comparison of clinical and histopathologic features of childhood malignant lymphoma in Uganda.
    Magrath IT; Ziegler JL; Templeton AC
    Cancer; 1974 Jan; 33(1):285-94. PubMed ID: 4589321
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features and treatment of childhood malignant lymphoma in Uganda.
    Ziegler JL; Morrow RH; Templeton AC; Templeton C; Bluming AZ; Fass L; Kyalwazi SK
    Int J Cancer; 1970 May; 5(3):415-25. PubMed ID: 4916223
    [No Abstract]   [Full Text] [Related]  

  • 3. Childhood non-Hodgkin's lymphoma--a study of 17 cases in Israel.
    Aghai E; Hulu N; Virag I; Kende G; Ramot B
    Cancer; 1974 May; 33(5):1411-6. PubMed ID: 4362957
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant lymphomas in children. A clinico-pathologic retrospective study. II. Non-Hodgkin's lymphomas.
    Garwicz S; Landberg T; Akerman M
    Acta Paediatr Scand; 1974 Sep; 63(5):679-86. PubMed ID: 4606779
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of patients with non-Hodgkin's lymphoma.
    Carbone PP
    Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-Hodgkin's lymphomas and malignant histiocytosis in children.
    Dehner LP
    Semin Oncol; 1977 Sep; 4(3):273-86. PubMed ID: 335517
    [No Abstract]   [Full Text] [Related]  

  • 7. Burkitt's tumor and childhood lymphosarcoma.
    Wright DH
    Clin Pediatr (Phila); 1967 Feb; 6(2):116-23. PubMed ID: 5630405
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.
    Sherins RJ; DeVita VT
    Ann Intern Med; 1973 Aug; 79(2):216-20. PubMed ID: 4580112
    [No Abstract]   [Full Text] [Related]  

  • 9. The "large cell" malignant lymphomas. A retrospective morphological analysis.
    Leahu S
    Med Interne; 1980; 18(3):333-8. PubMed ID: 6997976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of Burkitt's lymphoma of the face and jaws.
    Ziegler JL; Wright DH; Kyalwazi SK
    Cancer; 1971 Mar; 27(3):503-14. PubMed ID: 4994331
    [No Abstract]   [Full Text] [Related]  

  • 11. Soft Tissue B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma Diagnosed by Fine Needle Aspiration Cytology.
    Beljan Perak R; Pavlovic A; Lozic B; Sundov D; Piljic Burazer M; Soljic V
    Acta Cytol; 2015; 59(4):355-7. PubMed ID: 26315277
    [No Abstract]   [Full Text] [Related]  

  • 12. High dose imtermittent intravenous cyclophosphamide in non-Hodgkin's lymphomas: long-term patient follow-up.
    O'Connell MJ; Wiernik PH; Sutherland JC
    Oncology; 1976; 33(4):170-2. PubMed ID: 798149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior mediastinal compression: a report of five cases by malignant lymphoma.
    Olumide AA; Osunkoya BO; Ngu VA
    Cancer; 1971 Jan; 27(1):193-202. PubMed ID: 5107431
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology.
    Okudaira T; Nagasaki A; Miyagi T; Taira T; Ohshima K; Takasu N
    Intern Med; 2009; 48(6):475-8. PubMed ID: 19293550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Hodgkin's lymphoma: recent observations on natural history and intensive treatment.
    Carbone PP
    Cancer; 1972 Dec; 30(6):1511-6. PubMed ID: 4565816
    [No Abstract]   [Full Text] [Related]  

  • 16. Germinal center and activated b-cell profiles separate Burkitt lymphoma and diffuse large B-cell lymphoma in AIDS and non-AIDS cases.
    Gormley RP; Madan R; Dulau AE; Xu D; Tamas EF; Bhattacharyya PK; LeValley A; Xue X; Kumar P; Sparano J; Ramesh KH; Pulijaal V; Cannizzaro L; Walsh D; Ioachim HL; Ratech H
    Am J Clin Pathol; 2005 Nov; 124(5):790-8. PubMed ID: 16203284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment outcome in primary testicular non-Hodgkin lymphoma].
    Iványi JL; Marton E; Plander M; Engert ZV; Tóth C
    Orv Hetil; 2013 Oct; 154(42):1666-73. PubMed ID: 24121219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.
    Rieken J; Bernard V; Witte HM; Peter W; Merz H; Olschewski V; Hertel L; Lehnert H; Biersack H; von Bubnoff N; Feller AC; Gebauer N
    Br J Haematol; 2021 Apr; 193(1):138-149. PubMed ID: 32945554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of the lymphomas.
    DeVita VT; Canellos GP
    Semin Hematol; 1972 Apr; 9(2):193-209. PubMed ID: 4111886
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.